Search results
Results from the WOW.Com Content Network
Pages in category "Biotechnology companies of the United Kingdom" The following 31 pages are in this category, out of 31 total. This list may not reflect recent changes .
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Note: the activities of the parent companies of many of the companies listed below are not restricted solely to the United Kingdom. For example, AstraZeneca and GlaxoSmithKline , although headquartered in the United Kingdom, have activities in numerous other countries, and Johnson & Johnson and Pfizer are both headquartered in the United States ...
In 2015, the UK had around 225 main biotechnology companies, turning over around £2.9bn. [2] Exports accounted for around £1.5bn of turnover. The UK has an estimated 5% share of the global market. In Europe, by patent applications submitted under the Patent Cooperation Treaty, the UK is third, second to Germany and France but seventh in the ...
In December 2005, the company acquired KuDOS Pharmaceuticals, a UK biotech company, for £120 million. [20] and entered into an anti-cancer collaboration agreement with Astex. [21] That same year, the firm also became a Diamond Member of the Pennsylvania Bio commerce organisation. [22]
The UK is home to GlaxoSmithKline and AstraZeneca, respectively the world's fifth- and sixth-largest pharmaceutical companies measured by 2009 market share. [8] It is also home to the multinational Hikma Pharmaceuticals. Foreign companies with a major presence in the UK pharmaceutical industry include Pfizer, Novartis, [9] Hoffmann–La Roche ...
The company was established in 1995 as a spin out from the University of Oxford. [3] It was the subject of an initial public offering on the Alternative Investment Market in 1996. [4] In 2018, OXBs gene therapy for Parkinson's disease became the subject of a commercialization deal with Axovant Sciences. [5]
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.